2025
SJR Q2
JCR Q2 · 2,6
SCIE
Journal detail
Cancer Genomics and Proteomics
- Publisher
- International Institute of Anticancer Research
- Country
- Greece · Western Europe
- Type
- journal
- ISSN
-
1109653517906245
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,807
- Quartile Q2
- H-Index 53
- Cites/doc 2,66
- Docs (3y) 183
- Cites (3y) 533
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,6
- 5Y JIF 2,5
- JCI 0,67
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Biochemistry Q2
- Cancer Research Q3
- Genetics Q2
- Medicine (miscellaneous) Q2
- Molecular Biology Q3
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Oncology | Genetics & Heredity
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,807 | 2,6 | 2,5 | 0,67 | Q2 | 53 |
| 2024 | Q2 | Q2 | 0,697 | 2,6 | 2,4 | 0,68 | Q2 | 51 |
| 2023 | Q2 | Q2 | 0,722 | 2,6 | 3,1 | 0,7 | Q2 | 51 |
| 2022 | Q2 | Q3 | 0,66 | 2,5 | 3,4 | 0,64 | Q3 | 51 |
| 2021 | Q2 | Q3 | 0,748 | 3,4 | 3,8 | 0,73 | Q2 | 51 |
| 2020 | Q1 | Q2 | 1,234 | 4,1 | 3,7 | 0,78 | Q2 | 51 |
| 2019 | Q1 | Q2 | 1,039 | 3,3 | 2,7 | 0,73 | Q2 | 51 |
| 2018 | — | Q2 | — | 3,1 | 2,6 | 0,73 | Q2 | — |
| 2017 | Q2 | Q3 | 0,818 | 2,4 | 2,8 | 0,62 | Q3 | 51 |
| 2016 | Q1 | Q3 | 0,996 | 1,9 | 2,2 | — | — | 51 |
| 2015 | Q1 | Q2 | 1,109 | 2,8 | — | — | — | 51 |
| 2014 | Q1 | Q2 | 1,285 | 2,7 | — | — | — | 51 |
| 2013 | Q1 | Q3 | 0,881 | 1,9 | — | — | — | 51 |
| 2012 | Q2 | — | 0,785 | — | — | — | — | 51 |
| 2011 | Q2 | — | 0,779 | — | — | — | — | 51 |
| 2010 | Q2 | — | 0,735 | — | — | — | — | 51 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | GENETICS & HEREDITY | SCIE | Q2 | Q2 | 96/192 |
| 2025 | ONCOLOGY | SCIE | Q3 | Q2 | 196/333 |
| 2024 | GENETICS & HEREDITY | SCIE | Q2 | Q2 | 90/192 |
| 2024 | ONCOLOGY | SCIE | Q3 | Q2 | 181/328 |
| 2023 | GENETICS & HEREDITY | SCIE | Q2 | Q2 | 91/191 |
| 2023 | ONCOLOGY | SCIE | Q3 | Q2 | 175/322 |
| 2022 | GENETICS & HEREDITY | SCIE | Q3 | Q3 | 108/171 |
| 2022 | ONCOLOGY | SCIE | Q4 | Q3 | 184/241 |
| 2021 | GENETICS & HEREDITY | SCIE | Q3 | Q2 | 89/175 |
| 2021 | ONCOLOGY | SCIE | Q3 | Q2 | 163/245 |
| 2020 | GENETICS & HEREDITY | SCIE | Q2 | Q2 | 69/176 |
| 2020 | ONCOLOGY | SCIE | Q3 | Q2 | 127/242 |
| 2019 | GENETICS & HEREDITY | SCIE | Q2 | Q3 | 73/178 |
| 2019 | ONCOLOGY | SCIE | Q3 | Q2 | 125/244 |
| 2018 | GENETICS & HEREDITY | SCIE | Q2 | Q3 | 66/174 |
| 2018 | ONCOLOGY | SCIE | Q2 | Q2 | 109/230 |
| 2017 | GENETICS & HEREDITY | SCIE | Q3 | Q3 | 94/171 |
| 2017 | ONCOLOGY | SCIE | Q3 | Q3 | 153/223 |
| 2016 | GENETICS & HEREDITY | SCIE | Q3 | — | 111/167 |
| 2016 | ONCOLOGY | SCIE | Q4 | — | 165/217 |
| 2015 | GENETICS & HEREDITY | SCIE | Q2 | — | 71/166 |
| 2015 | ONCOLOGY | SCIE | Q3 | — | 114/213 |
| 2014 | GENETICS & HEREDITY | SCIE | Q2 | — | 75/167 |
| 2014 | ONCOLOGY | SCIE | Q3 | — | 116/211 |
| 2013 | GENETICS & HEREDITY | SCIE | Q3 | — | 119/165 |
| 2013 | ONCOLOGY | SCIE | Q3 | — | 146/203 |